Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
t-cell entities : Phio pharmaceuticals corp. save search
Intratumoral Injection of Phio’s PH-762 significantly inhibits tumor growth in murine tumor models and may generate memory-specific T cells
Published: 2024-04-22 (Crawled : 17:00) - globenewswire.com
PHIO | News | $0.8271 29.26% 22.63% 7.2M
|
Health Technology
|
| O: -1.56%
H: 66.67%
C: 31.75%
ph-762 tumor injection growth
Phio Pharmaceuticals Presents Preclinical Study Showing PH-762 Induces Systemic Memory T Cell Mediators of Anti-Tumor Immunity
Published: 2023-04-17 (Crawled : 12:00) - investors.phiopharma.com
PHIO | News | $0.8271 29.26% 22.63% 7.2M
|
Health Technology
|
| O: 10.3%
H: 17.14%
C: 7.42%
ph-762 cell pharmaceuticals preclinical study
Phio Pharmaceuticals Announces Preclinical Data Demonstrating PH-762 Enhances Persistence of T cells for Tumor Cell Killing as Presented by Helmholtz Munich at the 9th Immunotherapy of Cancer Conference
Published: 2022-09-22 (Crawled : 12:00) - prnewswire.com
PHIO | News | $0.8271 29.26% 22.63% 7.2M
|
Health Technology
|
| O: 3.85%
H: 0.74%
C: -5.19%
ph-762 pharmaceuticals conference preclinical immunotherapy cancer
Phio Pharmaceuticals Presents New Data Demonstrating PH-894 Enhances Activity of HER2-CAR-T Cells at ASGCT 2022
Published: 2022-05-16 (Crawled : 12:00) - investors.phiopharma.com
PHIO | News | $0.8271 29.26% 22.63% 7.2M
|
Health Technology
|
| O: 3.49%
H: 6.15%
C: 0.3%
ph-894 ph94 her2- her2
Phio Pharmaceuticals Presents Positive In Vivo Data at ASGCT Showing PH-762 Significantly Enhanced Antitumor Efficacy of HER2-Targeted CAR-T Cells
Published: 2021-05-11 (Crawled : 12:00) - investors.phiopharma.com
PHIO | News | $0.8271 29.26% 22.63% 7.2M
|
Health Technology
|
| O: -5.88%
H: 2.5%
C: -8.75%
positive car-t her2+ t-cell her2- her2
Phio Pharmaceuticals and AgonOx, Inc. Announce Collaboration on Clinical Development of Novel T Cell-based Cancer Immunotherapies
Published: 2021-03-01 (Crawled : 13:12) - investors.phiopharma.com
PHIO | News | $0.8271 29.26% 22.63% 7.2M
|
Health Technology
|
| O: 11.54%
H: 4.08%
C: -3.45%
collaboration cancer t-cell announces collaboration immunotherapy
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.565 105.2% 51.27% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.91 48.81% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Your saved searches
Save your searches and get alerts when important news are released.